Anaplastic lymphoma kinase-special immunity and immunotherapy

Alterations in the anaplastic lymphoma kinase (ALK) gene play a key role in the development of various human tumors, and targeted therapy has transformed the treatment paradigm for these oncogene-driven tumors. However, primary or acquired resistance remains a challenge. ALK gene variants (such as g...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Ye, Guo, Hanfei, Zhang, Yongfei, Cui, Jiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359062/
https://www.ncbi.nlm.nih.gov/pubmed/35958559
http://dx.doi.org/10.3389/fimmu.2022.908894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359062/
https://www.ncbi.nlm.nih.gov/pubmed/35958559
http://dx.doi.org/10.3389/fimmu.2022.908894

Ejemplares similares